Abstract
Objective To examine data on COVID-19 disease associated with a 10 percent increase in U.S. road deaths from 2020 to 2021 that raises the question of the potential effect of pandemic stress and neurological damage from COVID-19 disease.
Methods Poisson regression was used to estimate the association of recent COVID-19 cases, accumulated cases, maximum temperatures, truck registrations, and gasoline prices with road deaths monthly among U.S. states in 2021. Using the regression coefficients, changes in each risk factor from 2020 to 2021 were used to calculate expected deaths in 2021 if each factor had remained the same as in 2020.
Results Corrected for the other risk factors, road deaths were associated with accumulated COVID-19 cases but not cases in the previous month. More than 20,700 road deaths were associated with the changes in accumulated COVID-19 cases but were substantially offset by about 19,100 less-than-expected deaths associated with increased gasoline prices.
Conclusions While more research is needed, the data are sufficient to warn people with “long COVID” to minimize road use.
What is already known about this topic Previous short-term fluctuations in road deaths are related to changes in temperature, fuel prices, and truck registrations.
What this study adds Corrected for other risk factors, the monthly changes in road deaths from 2020 to 2021 in U.S. states were associated with cumulative COVID-19 cases.
How this study might affect research, practice, or policy Studies are needed to distinguish the potential relative effects of neurological damage as well as the stress of coping with the pandemic on driving, walking, and bicyclist behavior. Warning people with “long covid” about road risk is warranted.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at:9.National Centers for Environmental Information. Climate data online. National Oceanic and Atmospheric Administration. March 2023: https://www.ncdc.noaa.gov/cdo-web/ 10.Federal Highway Administration. State motor-vehicle registrations. Highway Statistics 2021. March 2023. https://www.fhwa.dot.gov/policyinformation/statistics/2021/ 11.U.S. Energy Information Administration. Petroleum and other liquids. March 10, 2022. https://www.eia.gov/dnav/pet/hist/LeafHandler.ashx?n=pet&s=emm_epm0_pte_nus_dpg&f=m 12.U.S. Centers for Disease Control and Prevention. United States COVID-19 cases and deaths by state over time. March 10, 2023. https://data.cdc.gov/Case-Surveillance/United-States-COVID-19-Cases-and-Deaths-by-State-o/9mfq-cb36 13.National Highway Traffic Safety Administration. Fatality Analysis Reporting System. May 2022. https://www.nhtsa.gov/research-data/fatality-analysis-reporting-system-fars 14.U.S. Census Bureau. National population totals and components of change: 2020-2021. March 2023. https://www.census.gov/data/datasets/time-series/demo/popest/2020s-national-total.html
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
E-mail: leon.robertson{at}yale.edu
Disclosure: This research was not funded. The author has no financial or other interests that would be affected by publication.
Data availability: Data sources are publically available at the websites cited.
Data Availability
9. National Centers for Environmental Information. Climate data online. National Oceanic and Atmospheric Administration. March 2023: https://www.ncdc.noaa.gov/cdo-web/ 10. Federal Highway Administration. State motor-vehicle registrations. Highway Statistics 2021. March 2023. https://www.fhwa.dot.gov/policyinformation/statistics/2021/ 11. U.S. Energy Information Administration. Petroleum and other liquids. March 10, 2022. https://www.eia.gov/dnav/pet/hist/LeafHandler.ashx?n=pet&s=emm_epm0_pte_nus_dpg&f=m 12. U.S. Centers for Disease Control and Prevention. United States COVID-19 cases and deaths by state over time. March 10, 2023. https://data.cdc.gov/Case-Surveillance/United-States-COVID-19-Cases-and-Deaths-by-State-o/9mfq-cb36 13. National Highway Traffic Safety Administration. Fatality Analysis Reporting System. May 2022. https://www.nhtsa.gov/research-data/fatality-analysis-reporting-system-fars 14. U.S. Census Bureau. National population totals and components of change: 2020-2021. March 2023. https://www.census.gov/data/datasets/time-series/demo/popest/2020s-national-total.html
